PAID CLINICAL TRIAL
- Lasting 5 months
- 11 clinic visits
YOU MAY BE ELIGIBLE TO PARTICIPATE IF YOU MEET THE FOLLOWING CRITERIA:
- Currently taking Semaglutide/Wegovy for a minimum of 3 months
- Are 18 years of age or older
The purpose of this study is to evaluate the safety and tolerability of various aleniglipron dose regimens in participants who are living with obesity or diagnosed as overweight that have been on stable treatment with an injectable GLP-1RA (semaglutide) and have responded to treatment.
Lynn Institute is a leader in introducing new medications to the market through our clinical trials program. Visit our Participation Information page for Frequently Asked Questions, to see current clinical trials listed, and to find out where each trial is being conducted.
Find out More About Our Participation Program
Participation Information